ロード中...
Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation
Elevated levels of erythropoietin (EPO) are associated with an increased risk of death in renal transplant recipients (RTRs), but the underlying mechanisms remain unclear. Emerging data suggest that EPO stimulates production of the phosphaturic hormone fibroblast growth factor 23 (FGF23), another st...
保存先:
| 出版年: | J Clin Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7356141/ https://ncbi.nlm.nih.gov/pubmed/32512806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061737 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|